Glow in Seoul

Name decoder · Laser

Clarity: Lutronic’s two-wavelength laser on Korean menus

클라리티

Checked 2026-10-23. Prepared with AI assistance from the sources listed below; not reviewed by a doctor. Not medical advice.

클라리티 (Clarity) on a Korean menu is a Lutronic laser family that includes the earlier Clarity LPC and the current Clarity II, which combines 755 nm alexandrite and 1064 nm Nd:YAG with millisecond pulses; the menu name alone does not tell you the model.[1][2] Korean clinics use it for hair removal and, often bundled with pico toning, for spots and redness.[3][4]

Clarity II’s US clearance covers hair reduction plus benign pigmented and vascular lesions and wrinkles, based on equivalence to earlier devices without new clinical data. Its Korean approvals use generic laser-surgery wording, and its 2026 Japanese approval, per the maker, is for hair reduction only.[2][5][6]

At a glance

Korean names
클라리티, 클라리티2, 클라리티 II, 클라리티 프리미엄.[3][7]
Maker
Lutronic, Goyang, Korea; part of Cynosure Lutronic since a 2024 merger.[2][6]
Clarity II
755 nm alexandrite and 1064 nm Nd:YAG in one unit; pulses of 0.1–300 milliseconds; cooled by cryogen spray (ICD) or chilled air (AIR).[2]
Korean approval
Class 3 alexandrite and Nd:YAG laser surgical units, first approved in 2012; Clarity II models in 2019 and 2026, on technical documents rather than clinical data.[5]
US clearances
K130199 (Clarity LPC, 2013) and K183566 (Clarity II, 2019). The K130199 summary says no performance data were presented; the K183566 summary lists bench testing and no clinical data.[1][2]
How it is sold
Hair removal packages of 5 or 12 sessions; for spots and redness, single sessions or bundles with pico toning, IPL or a skin booster. One clinic suggests 3–5 sessions 3–4 weeks apart.[3][4][8][9]
Models and versions
Clarity II

In Korean searches

Among the 33 treatments we track on Naver, Clarity laser ranks #30 by Korean search interest (index 2; the most-searched = 100). Too few related search terms to break down what people ask. Google searches in Korea for its main Korean name: +42% in Jul 2026–Sep 2026 compared with Oct 2025–Dec 2025.

From the Korea Treatment Radar, October 2026. Search interest, not treatments performed.

Spots and redness: what studies show

For freckles and age spots in Chinese patients, a split-face trial of 20 people found long-pulse and Q-switched alexandrite lasers both improved pigment, with dark marks after treatment in 6% and 22% respectively.[10] A small retrospective comparison by the same group found no significant improvement with long-pulse alexandrite and dark marks in 20%.[11] The evidence is small and conflicting.

In a single-arm study of 21 Korean patients with rosacea, a measured redness index fell after three monthly Clarity II sessions; without a control group, it cannot show how much of that the laser caused.[12]

Melasma (기미)

The US clearance lists chloasma (melasma) among the pigmented lesions for the 1064 nm wavelength; that is cleared wording, not proof that it works.[2] A 2026 meta-analysis of laser treatment for melasma rated the evidence of very low certainty, and a 2026 review warns of dark marks after laser treatment, especially in darker skin.[13][14]

Safety notices

In February 2026 the maker issued an EU field safety notice for Clarity II units with cryogen cooling: at high-fluence 1064 nm settings, mismatched cooling times can raise the risk of superficial burns. It reported no serious injuries.[15] A Korean recall, now closed, addressed with a software update a delay in the skin-temperature display that could stop the overheating cut-off from acting in time.[5]

Not the same as

  • Pico toning (PicoSure, PicoWay): picosecond pulses; Clarity’s pulses are milliseconds, and clinics sell the two together.[16][2]
  • Q-switched laser toning: nanosecond pulses, a different pulse regime.[10]
  • Laser hair removal (레이저 제모): one use of this device, not its name.[3]

Questions to ask the clinic

  1. Which Clarity model is this, and which wavelength will you use for my concern?
  2. Is today’s session for hair, spots or redness? For spots, are you treating individual spots or the whole face?
  3. I have melasma (기미). Would you use this laser for it, and what is your plan if it darkens?
  4. Is it bundled with pico toning or IPL, and what does each part do?
  5. How many sessions, how far apart, and what if spots crust before my flight home?
  6. Who operates the laser?

Sources

  1. US FDA 510(k) K130199: CLARITY LPC Laser System, November 22, 2013↩1↩2
  2. US FDA 510(k) K183566: Lutronic CLARITY II Laser System, June 14, 2019↩1↩2↩3↩4↩5↩6↩7
  3. Clinic listing on Gangnam Unni: Clarity II hair removal packages (usage)↩1↩2↩3↩4
  4. Clinic listing on Gangnam Unni: Clarity plus pico toning (usage)↩1↩2
  5. MFDS medical device register: CLARITY and CLARITY II models, 2012–2026, with a closed recall record (search “CLARITY”)↩1↩2↩3
  6. Cynosure Lutronic press release, March 3, 2026: Clarity II approvals in Japan and China (Japanese)↩1↩2
  7. Clinic listing on Gangnam Unni: pico toning plus Clarity Premium (usage)↩
  8. Clinic listing on Gangnam Unni: Clarity for redness, with IPL and skin booster bundles (usage)↩
  9. Seoul clinic page on Clarity, medical review May 2026 (usage)↩
  10. Ho SG et al. Lasers Surg Med 2011;43:108–113: long-pulse versus Q-switched alexandrite for freckles and lentigines, split-face, 20 patients↩1↩2
  11. Ho SG et al. J Cosmet Laser Ther 2012;14:74–80: retrospective comparison of four pigment lasers, 40 patients↩
  12. Park S et al. Photodermatol Photoimmunol Photomed 2024: Clarity II long-pulse alexandrite for rosacea redness, 21 patients↩
  13. Aljoaib et al. Cureus 2026: systematic review and meta-analysis of lasers for melasma↩
  14. Campos et al. Dermatol Clin 2026: review of melasma treatment↩
  15. Lutronic field safety notice LUT-FSN-2026-001, February 10, 2026 (ANSM copy, French)↩
  16. US FDA 510(k) K121346: PicoSure↩

Manufacturer pages establish what a product is, not that it works. Regulatory filings describe what a regulator cleared or approved in that country. Glow in Seoul editorial; no clinic paid for or reviewed this page. See our transparency page.